• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    9/27/23 12:48:37 PM ET
    $ADES
    $AONC
    $APLS
    $AU
    Major Chemicals
    Industrials
    Medical/Nursing Services
    Health Care
    Get the next $ADES alert in real time by email

    Gainers

    ShiftPixy, Inc. (NASDAQ:PIXY) shares jumped 152.8% to $1.09. The company announced the effective date for its reverse stock split after the close. Shareholders voted to approve a reverse split on Aug. 21. After the closing bell on Tuesday, ShiftPixy said the one-for-twenty-four reverse split will take effect on Sept. 30.

    SciSparc Ltd. (NASDAQ:SPRC) gained 120.9% to $0.3450. The company reported its previously announced 1-for-26 reverse share split is expected to be implemented after market close today.

    Rite Aid Corporation (NYSE:RAD) climbed 44% to $0.6175. Consulting firm McKinsey & Company has reached a substantial settlement agreement of $230 million to resolve lawsuits filed by numerous U.S. local governments and school districts, accusing the firm of contributing to the opioid addiction crisis through its consulting work with OxyContin maker Purdue Pharma and other pharmaceutical companies.

    MillerKnoll, Inc. (NASDAQ:MLKN) surged 27% to $24.31 after the company announced better-than-expected first-quarter financial results and issued FY24 EPS guidance above estimates.

    Biohaven Ltd. (NYSE:BHVN) shares gained 24.6% to $21.99.

    American Strategic Investment Co. (NYSE:NYC) climbed 22.8% to $7.64 after Bellevue Capital Partners, LLC launched a tender offer for shares of the company.

    Inpixon (NASDAQ:INPX) gained 18.4% to $0.1512.

    MSP Recovery, Inc. (NASDAQ:LIFW) shares climbed 18.3% to $0.1799 after falling around 25% on Tuesday.

    Gaucho Group Holdings, Inc. (NASDAQ:VINO) gained 18.2% to $2.4699 after falling over 12% on Tuesday. Gaucho Group recently announced a 1-for-10 reverse stock split.

    Galecto, Inc. (NASDAQ:GLTO) shares climbed 17.3% to $0.6740 after the company announced plans to explore strategic alternatives.

    Phoenix New Media Limited (NYSE:FENG) climbed 16% to $1.3004 as the company announced up to $2 million share repurchase program.

    Ramaco Resources, Inc. (NASDAQ:METC) rose 15.3% to $10.77.

    SoundHound AI, Inc. (NASDAQ:SOUN) gained 15% to $1.84 after DA Davidson initiated coverage on the stock with a Buy rating and $5 price target.

    VBI Vaccines Inc. (NASDAQ:VBIV) rose 14% to $0.7142 as the company Announced interim data from the Phase 1 study of its multivalent pan-coronavirus vaccine candidate, VBI-2901.

    Finance Of America Companies Inc. (NYSE:FOA) gained 14% to $1.39.

    Advanced Emissions Solutions, Inc. (NASDAQ:ADES) climbed 11.7% to $1.7095.

    Warrior Met Coal, Inc. (NYSE:HCC) surged 10.5% to $51.93.

    Immunovant, Inc. (NASDAQ:IMVT) climbed 10.2% to $44.04 as the company reported a proposed offering of $300 million of common stock.

    PROS Holdings, Inc. (NYSE:PRO) surged 9.4% to $35.00. PROS Holdings is working with Qatalyst Partners to explore a sale, Reuters reported.

    WW International, Inc. (NASDAQ:WW) gained 7.2% to $11.03. Craig-Hallum upgraded WW International from Sell to Hold.

    Cardiff Oncology, Inc. (NASDAQ:CRDF) shares gained 7% to $1.73 after the company announced clinical data in pancreatic cancer and small cell lung cancer, including single-agent activity from onvansertib monotherapy.

    Losers

    mCloud Technologies Corp. (NASDAQ:MCLD) shares dipped 45.5% to $0.1569 after the company said it would not meet the listing requirements of the Nasdaq Stock Market LLC.

    Know Labs, Inc. (NYSE:KNW) fell 32.3% to $0.24 after the company announced pricing of a $7 million public offering of common stock.

    Sharps Technology, Inc. (NASDAQ:STSS) fell 31.6% to $0.56 after the company reported a $5.6 million registered direct and private placement priced at the market under Nasdaq rules.

    XWELL, Inc. (NASDAQ:XWEL) dipped 29.9% to $0.1142. XWELL announced a 1-for-20 reverse stock split.

    Minerva Surgical, Inc. (NASDAQ:UTRS) fell 29.6% to $0.1990 after jumping 55% on Tuesday.

    Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) tumbled 26.4% to $1.8099 after the company announced an "at-the-market" equity offering program.

    Femasys Inc. (NASDAQ:FEMY) dipped 25% to $1.11. Femasys shares jumped 346% on Tuesday after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.

    Tharimmune, Inc. (NASDAQ:THAR) fell 24.4% to $0.2222 after surging 33% on Tuesday.

    Conduit Pharmaceuticals Inc. (NASDAQ:CDT) fell 19% to $5.32 after declining more than 36% on Tuesday.

    Cheche Group Inc. (NASDAQ:CCG) declined 17.4% to $13.31.

    NextEra Energy Partners, LP (NYSE:NEP) fell 17.2% to $38.82 after the company announced it is revising its limited partner distribution per unit growth rate to 5% to 8% per year through at least 2026.

    Soleno Therapeutics, Inc. (NASDAQ:SLNO) tumbled 15.8% to $22.55.

    Avinger, Inc. (NASDAQ:AVGR) fell 15.5% to $6.43. Avinger raised gross proceeds of approximately $5.3 million through its at-the-market, selling an aggregate of 596,200 shares at a weighted average price of $8.97.

    DMK Pharmaceuticals Corporation (NASDAQ:DMK) declined 15.2% to $0.6499. The company was recently granted a Canadian patent titled 'An Opioid For Use To Reduce And/Or Treat Drug Addiction.'

    TransCode Therapeutics, Inc. (NASDAQ:RNAZ) fell 13.5% to $0.5969. TransCode Therapeutics recently priced its $8 million public offering of 15.7 million shares at $0.51/share.

    Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) declined 12% to $37.98.

    American Oncology Network, Inc. (NASDAQ:AONC) fell 11.3% to $11.63.

    Axcella Health Inc. (NASDAQ:AXLA) fell 11% to $7.07 after declining around 10% on Tuesday.

    VinFast Auto Ltd. (NASDAQ:VFS) declined 9.3% to $11.68.

    PolyPid Ltd. (NASDAQ:PYPD) fell 9% to $4.8980 after declining 4% on Tuesday. PolyPid recently announced a successful Good Manufacturing Practice (GMP) audit by the Israeli Ministry of Health.

    Traeger, Inc. (NYSE:COOK) fell 8.1% to $2.60. Morgan Stanley downgraded Traeger from Equal-Weight to Underweight and lowered the price target from $4.75 to $3.

    AngloGold Ashanti Limited (NYSE:AU) declined 7.2% to $16.87.

    Wabash National Corporation (NYSE:WNC) fell 7% to $20.60. DA Davidson downgraded Wabash National from Buy to Neutral and announced a $25 price target.

    Now Read This: Ethereum Tops $1,600; Maker, Injective Among Top Gainers

    Get the next $ADES alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADES
    $AONC
    $APLS
    $AU

    CompanyDatePrice TargetRatingAnalyst
    Traeger Inc.
    $COOK
    3/6/2026$1.50 → $1.00Market Perform
    Telsey Advisory Group
    Galecto Inc.
    $GLTO
    2/17/2026$45.00Buy
    UBS
    MillerKnoll Inc.
    $MLKN
    2/10/2026Outperform
    William Blair
    Biohaven Ltd.
    $BHVN
    2/6/2026$23.00Buy
    Goldman
    Warrior Met Coal Inc.
    $HCC
    1/29/2026$108.00Neutral → Buy
    UBS
    Apellis Pharmaceuticals Inc.
    $APLS
    1/28/2026$24.00Equal Weight
    Barclays
    Biohaven Ltd.
    $BHVN
    1/21/2026$22.00Sector Perform → Outperform
    RBC Capital Mkts
    Apellis Pharmaceuticals Inc.
    $APLS
    1/21/2026$28.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $ADES
    $AONC
    $APLS
    $AU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF FINANCIAL OFFICER Fulk Jennifer was granted 39,200 shares (SEC Form 4)

    4 - SOLENO THERAPEUTICS INC (0001484565) (Issuer)

    3/4/26 5:59:56 PM ET
    $SLNO
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 3 filed by new insider Fulk Jennifer

    3 - SOLENO THERAPEUTICS INC (0001484565) (Issuer)

    3/4/26 5:58:24 PM ET
    $SLNO
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    President Sieffert Kristen N sold $14,115 worth of shares (750 units at $18.82), decreasing direct ownership by 0.94% to 78,799 units (SEC Form 4)

    4 - Finance of America Companies Inc. (0001828937) (Issuer)

    3/4/26 4:08:29 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    $ADES
    $AONC
    $APLS
    $AU
    SEC Filings

    View All

    Traeger Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Traeger, Inc. (0001857853) (Filer)

    3/6/26 8:31:30 AM ET
    $COOK
    Consumer Electronics/Appliances
    Consumer Discretionary

    SEC Form 144 filed by AngloGold Ashanti PLC

    144 - AngloGold Ashanti PLC (0001973832) (Subject)

    3/6/26 7:43:58 AM ET
    $AU
    Precious Metals
    Basic Materials

    SEC Form 6-K filed by AngloGold Ashanti PLC

    6-K - AngloGold Ashanti PLC (0001973832) (Filer)

    3/6/26 6:01:20 AM ET
    $AU
    Precious Metals
    Basic Materials

    $ADES
    $AONC
    $APLS
    $AU
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for EMPAVELI issued to APELLIS PHARMACEUTICALS INC

    Submission status for APELLIS PHARMACEUTICALS INC's drug EMPAVELI (ORIG-1) with active ingredient PEGCETACOPLAN has changed to 'Approval' on 05/14/2021. Application Category: NDA, Application Number: 215014, Application Classification: Type 1 - New Molecular Entity

    5/17/21 11:09:40 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADES
    $AONC
    $APLS
    $AU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Schorsch Nicholas S bought $19,269 worth of shares (1,664 units at $11.58) (SEC Form 4)

    4 - American Strategic Investment Co. (0001595527) (Issuer)

    2/2/26 9:31:35 PM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    Large owner Schorsch Nicholas S bought $55,594 worth of shares (4,992 units at $11.14) (SEC Form 4)

    4 - American Strategic Investment Co. (0001595527) (Issuer)

    1/29/26 9:11:35 PM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    Large owner Schorsch Nicholas S bought $57,726 worth of shares (5,460 units at $10.57) (SEC Form 4)

    4 - American Strategic Investment Co. (0001595527) (Issuer)

    1/23/26 9:52:11 PM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    $ADES
    $AONC
    $APLS
    $AU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

    NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 05, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today notes the announcement issued by Sarborg Limited ("Sarborg") regarding the filing of a U.S. provisional patent application relating to its proprietary AI Signature Agent. CDT holds a 20% equity stake in Sarborg and views this filing as an important step in strengthening and formalising Sarborg's intellectual property position. Sarborg announced that a provisional patent application was filed with the United States Patent and Trademark Office on February 12, 2026, and has been assigned United States Patent Application No. 63/981,801. The application re

    3/5/26 8:30:00 AM ET
    $CDT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CDT Positions for Transformational Growth

    NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 04, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") advances multiple initiatives designed to enhance shareholder value and expand its strategic footprint. The Company continues to actively develop and expand its pharmaceutical asset portfolio, including solid-form and cocrystal development programs, alongside its licensed clinical assets AZD1656, AZD5658 and AZD5904 under its agreement with AstraZeneca. CDT remains engaged in ongoing evaluation and out-licensing discussions and continues to assess pathways to maximize the commercial and strategic potential of these assets. The Company believes this diversifi

    3/4/26 8:30:00 AM ET
    $CDT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    BOSTON, March 04, 2026 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ:GLTO), a biotechnology company working to redefine care for people with hematologic disorders, today announced that it granted equity awards on March 2, 2026, to four newly-hired, non-executive employees. The inducement grants were approved by Galecto's independent Compensation Committee and were made as material inducements to such individuals' acceptance of employment with Galecto in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement grants consist of non-qualified stock options to purchase an aggregate of 153,700 shares of the Galecto's common stock with a 10-year term and an exercise price of $29.58 per share

    3/4/26 8:00:00 AM ET
    $GLTO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADES
    $AONC
    $APLS
    $AU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Traeger with a new price target

    Telsey Advisory Group reiterated coverage of Traeger with a rating of Market Perform and set a new price target of $1.00 from $1.50 previously

    3/6/26 8:40:29 AM ET
    $COOK
    Consumer Electronics/Appliances
    Consumer Discretionary

    UBS initiated coverage on Galecto with a new price target

    UBS initiated coverage of Galecto with a rating of Buy and set a new price target of $45.00

    2/17/26 8:59:23 AM ET
    $GLTO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair initiated coverage on MillerKnoll

    William Blair initiated coverage of MillerKnoll with a rating of Outperform

    2/10/26 8:01:31 AM ET
    $MLKN
    Office Equipment/Supplies/Services
    Consumer Discretionary

    $ADES
    $AONC
    $APLS
    $AU
    Financials

    Live finance-specific insights

    View All

    Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system b

    2/27/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SoundHound AI Reports Record Annual Revenue of $169 Million, Up Nearly 100%, Forecasts Strong Growth

    SANTA CLARA, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- SoundHound AI, Inc. (NASDAQ:SOUN), a global leader in voice and conversational AI, today reported its financial results for the fourth quarter and full year 2025. "As traditional software faces massive AI disruption, businesses are looking to partner with AI natives that can help them achieve success in a new era. This is creating strong tailwinds for SoundHound," said Keyvan Mohajer, CEO and Co-Founder of SoundHound AI. "Our results speak for themselves. All key profit metrics were up and in the last quarter we closed a record number of customer deals as we capitalized on the surge in demand for enterprise-grade AI." Financial Hig

    2/26/26 4:06:00 PM ET
    $SOUN
    Computer Software: Prepackaged Software
    Technology

    RAMACO RESOURCES REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

    LEXINGTON, Ky., Feb. 25, 2026 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ:METC, METCB, ", Ramaco", or the ", Company", )) is a leading operator and developer of high-quality, low-cost metallurgical coal in Central Appalachia and is transitioning to also become a developer of rare earth and critical minerals in Wyoming. Today it reported financial results for the three and twelve month periods ending December 31, 2025 (the "Results"). FOURTH QUARTER 2025 HIGHLIGHTSThe Company had a quarterly net loss of $(14.7) million and Class A diluted EPS of $(0.26). Class A diluted EPS was $(0.22) excluding a $2.5 million one-time, non-recurring expense incurred in connection with the structuring of a

    2/25/26 4:25:00 PM ET
    $METC
    $METCB
    Coal Mining
    Energy

    $ADES
    $AONC
    $APLS
    $AU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by PolyPid Ltd.

    SC 13G/A - PolyPid Ltd. (0001611842) (Subject)

    12/12/24 7:05:07 AM ET
    $PYPD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Finance of America Companies Inc.

    SC 13D/A - Finance of America Companies Inc. (0001828937) (Subject)

    12/11/24 8:30:03 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    $ADES
    $AONC
    $APLS
    $AU
    Leadership Updates

    Live Leadership Updates

    View All

    Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors

    WALTHAM, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) announced today that Mikael Dolsten, M.D., Ph.D., has joined the company's board of directors as of March 1. Most recently, Dr. Dolsten served for more than 16 years as chief scientific officer and president, worldwide research, development and medical, at Pfizer, during which he presided over the regulatory approval of more than 36 medicines and vaccines.  "We are thrilled to welcome Mikael to the Apellis Board of Directors," said Cedric Francois, M.D., Ph.D., chief executive officer and co-founder, Apellis. "Mikael is a proven industry leader with deep experience developing innovative medicine

    3/2/26 7:00:00 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer

    REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ:SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the appointment of Jennifer Fulk as Chief Financial Officer, succeeding James Mackaness, who announced that he will be retiring from the Company by the end of the first quarter. Mr. Mackaness will serve as a consultant to Soleno through the end of the year to ensure a smooth transition. Mrs. Fulk brings to Soleno more than two decades of public company experience in leading financial strategy, investor relations, financial reporting, and operational efficiency, with a diverse c

    2/26/26 8:00:00 AM ET
    $SLNO
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer

    Leadership Expansion Supports Execution of Canton Network Infrastructure Strategy Former DRW and Citadel Leader Joins as COO to Drive Institutional Platform Expansion NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial markets, today announced that its Board of Directors (the "Board") has elected Mark Wendland, Chief Executive Officer, as Chairman of the Board and approved the appointment of Angela Radkowski as Chief Operating Officer, effective February 5, 2026. Mr. Wendland succeeds Vincent LoPriore, wh

    2/6/26 8:15:00 AM ET
    $THAR
    Biotechnology: Pharmaceutical Preparations
    Health Care